[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MX9700199A - Invariant chain compositions useful for treating autoimmune diseases. - Google Patents

Invariant chain compositions useful for treating autoimmune diseases.

Info

Publication number
MX9700199A
MX9700199A MX9700199A MX9700199A MX9700199A MX 9700199 A MX9700199 A MX 9700199A MX 9700199 A MX9700199 A MX 9700199A MX 9700199 A MX9700199 A MX 9700199A MX 9700199 A MX9700199 A MX 9700199A
Authority
MX
Mexico
Prior art keywords
invariant chain
peptide fragment
mhc
acid sequence
molecule
Prior art date
Application number
MX9700199A
Other languages
Spanish (es)
Inventor
William F Hickey
Original Assignee
Dartmouth College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dartmouth College filed Critical Dartmouth College
Priority claimed from PCT/US1995/008621 external-priority patent/WO1996001646A1/en
Publication of MX9700199A publication Critical patent/MX9700199A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Pharmaceutical compositions comprising an invariant chain protein, or peptide fragment thereof, and a pharmaceutically acceptable carrier are disclosed. An invariant chain peptide fragment of the composition comprises an amino acid sequence of a binding motif for a major histocompatibility complex (MHC) molecule, such as an MHC class II molecule. Preferably the peptide fragment is about 10 to 35 amino acids in length, more preferably 10 to 20 amino acids in length, even more preferably 12 to 16 amino acids in length. The invention further provides a method for preparing an invariant chain peptide fragment for use in the disclosed compositions and methods. This method involves identifying an amino acid sequence of a binding motif for an MHC molecule, selecting a region of an invariant chain protein comprising the amino acid sequence of the MHC binding motif and preparing an invariant chain peptide fragment encompassing the selected region. Methods for treating autoimmune diseases are also disclosed. The methods of the invention involve administering to a subject in need of treatment a therapeutically effective amount of an invariant chain protein, or peptide fragment thereof, optionally with a pharmaceutically acceptable carrier.
MX9700199A 1995-07-07 1995-07-07 Invariant chain compositions useful for treating autoimmune diseases. MX9700199A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/008621 WO1996001646A1 (en) 1994-07-08 1995-07-07 Invariant chain compositions useful for treating autoimmune diseases

Publications (1)

Publication Number Publication Date
MX9700199A true MX9700199A (en) 1998-01-31

Family

ID=39165370

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9700199A MX9700199A (en) 1995-07-07 1995-07-07 Invariant chain compositions useful for treating autoimmune diseases.

Country Status (1)

Country Link
MX (1) MX9700199A (en)

Similar Documents

Publication Publication Date Title
MX9703643A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein.
AU2987695A (en) Interruption of binding of mdm2 and p53 protein and therapeutic application thereof
DE69326064D1 (en) Human protein P53 peptides for use in human cytotoxic T cell response inducing compositions and human P53 protein specific T lymphocytes
IL141021A (en) Use of a polypeptide related to copolymer 1 for preparing a medicament for treating autoimmune diseases
CA2290485A1 (en) Method for the production of non-immunogenic proteins
DK0662827T4 (en) Therapeutic and diagnostic methods and compositions based on Notch proteins and nucleic acids
AU6020099A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
MY135057A (en) Dolastatin 15 derivatives
WO1996028470A3 (en) Peptide analogues of human myelin basic protein useful in treating multiple sclerosis
ATE219683T1 (en) METHOD AND PREPARATIONS FOR DELAYING OR PREVENTING AUTOIMMUNE DISEASES
ATE377026T1 (en) TREATMENT OF OBESITY
HUT62916A (en) Process for producing immunogenic peptides and pharmaceutical compositions comprising same
DE3584775D1 (en) COMPOSITION FOR TREATING DISEASES Suffering from HAEMOPHILIA-A-INHIBITOR.
DE69625682D1 (en) METHOD FOR TREATING IGNITIONS AND COMPOSITIONS THEREFOR
WO1996020950A3 (en) Compositions and methods for treating rheumatoid arthritis
FR2766190B1 (en) NOVEL PEPTIDES AND POLYPEPTIDES USEFUL IN THE REGENERATION OF THE NERVOUS SYSTEM
MX9700199A (en) Invariant chain compositions useful for treating autoimmune diseases.
DK0938329T3 (en) Immunogenic TLP composition
TR199700842T1 (en) �nsan DNase I Varyantlar�.
BG101846A (en) HUMAN DNase I VARIANTS
BR9006746A (en) PHYSIOLOGICALLY ACTIVE PEPTIDE AND REGULATORY AGENT OF CALCIUM METABOLISM
BG101847A (en) Human dnase i variants